Altis
Payments companies reported to CMS as associated with Altis. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Altis, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Altis
These are the largest totals companies reported as associated with Altis. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Costas Apostolis | Strongsville, OH | Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) | $315,985.84 |
| Mava Robinson-Walton | Silver Spring, MD | Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) | $148,450.09 |
| Vincent Lucente | Allentown, PA | Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) | $98,704.75 |
| Cheau Williams | Moultrie, GA | Urogynecology and Reconstructive Pelvic Surgery (Urology) | $88,951.93 |
| Ty Erickson | Idaho Falls, ID | Obstetrics & Gynecology | $85,691.62 |
| Diego Illanes | Milford, MA | Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) | $80,820.04 |
| Janet Harris-Hicks | Myrtle Beach, SC | Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) | $75,258.91 |
| Emily Cole | San Diego, CA | Urology | $69,671.30 |
| Nathan Kow | Orlando, FL | Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) | $59,722.49 |
| Jon Pennycuff | Madison, WI | Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) | $54,061.26 |
Prescribed Altis?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.